MedEffect e-Notice from Health Canada | Fibristal and Risk of Serious Liver Injury

Fibristal is a selective progesterone receptor modulator (SPRM) manufactured by Allergan Pharma Co. which is prescribed for the treatment of moderate to severe non-cancerous uterine fibroids. On March 15, 2018, Health Canada released a new MedEffect Notice indicating that, effective January 2018, Allergan Pharma Co. had updated its monograph for Fibristal to include warnings of […]

A Tribute to Lorna Hancock

We  you, Lorna! Grassroots activism to protect the rights and privilege of Canadians to choose natural health products and practices is not new. HANS (Health Action Network Society), established 38 years ago, organized a tribute dinner to celebrate the tireless work of its founding member and director, Lorna Hancock, on March 16, 2018 in Vancouver. Lorna […]